Invest in Iceland to Host Breakfast Reception at MaRs on Investment Opportunities in Icelandic Life Sciences

Topics include: Leveraging the Icelandic health data records and genomic data, pharmaceutical patent loopholes and opportunities in Biomedical research

TORONTO, March 21, 2018 /CNW/ - Invest in Iceland, a part of Promote Iceland –in collaboration with the Embassy of Iceland in Canada, Icelandic-Canadian Chamber of Commerce, World Trade Centre Toronto and the Toronto Region Board of Trade – invites media and investors to attend a breakfast reception on Thursday, March 22, at MaRs Discovery District in Toronto, Ontario. 

The reception will focus on the advantages of doing business in Iceland by showcasing Icelandic life sciences companies. It will also demonstrate how Invest in Iceland can assist life science companies considering starting or expanding business in Europe.

WHO:	Hosted by Invest in Iceland and the Embassy of Iceland, represented by Hlynur Guðjónsson, Consul General and Trade Commissioner for Iceland in North America.
WHAT:	Breakfast event with keynote speeches aimed at addressing Iceland's life sciences industries for investment. Speakers are Björn Lárus Örvar, Ph.D, co-founder of ORF, which created the skincare brand, BIOEFFECT; Einar Stefánsson, MD, Ph.D., a leading physician in the research of diabetic eye disease; and Chris McClure, Ph.D, consultant to Invest in Iceland.
WHERE:	MaRS Discovery District, CR3 Room: 101 College St, Toronto, ON M5G 1L7
WHEN:	Thursday, March 22, 2018 8:30 a.m. – 10:00 a.m.

For more details, please visit: http://seminar.investiniceland.org/

SOURCE Invest in Iceland

To confirm their attendance or arrange interviews, media are asked to contact: Jane Taber, NATIONAL Public Relations for Invest in Iceland, T 416-848-1450, [email protected].